Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Use of the GSK MenACWY-CRM/MenB-4C Pentavalent Meningococcal Vaccine Among Persons Aged ≥10 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2025

Saved in:
Bibliographic Details
Published in:MMWR Morbidity and Mortality Weekly Report
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1864030190276968450
collection WordPress RSS
FRELIP Feed Integration
container_title MMWR Morbidity and Mortality Weekly Report
description
discipline_display Social Sciences
discipline_facet Social Sciences
format Online Article
RSS Article
genre Journal Article
id rss_article:31944
institution FRELIP
journal_source_facet MMWR Morbidity and Mortality Weekly Report
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Use of the GSK MenACWY-CRM/MenB-4C Pentavalent Meningococcal Vaccine Among Persons Aged ≥10 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2025
— — — — — Demography and Population Studies
Psychology
Social Sciences
sub_discipline_display Psychology
sub_discipline_facet Psychology
subject_display — — — — — Demography and Population Studies
Psychology
Social Sciences
— — — — — Demography and Population Studies
Psychology
Social Sciences
subject_facet — — — — — Demography and Population Studies
Psychology
Social Sciences
title Use of the GSK MenACWY-CRM/MenB-4C Pentavalent Meningococcal Vaccine Among Persons Aged ≥10 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2025
title_auth Use of the GSK MenACWY-CRM/MenB-4C Pentavalent Meningococcal Vaccine Among Persons Aged ≥10 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2025
title_full Use of the GSK MenACWY-CRM/MenB-4C Pentavalent Meningococcal Vaccine Among Persons Aged ≥10 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2025
title_fullStr Use of the GSK MenACWY-CRM/MenB-4C Pentavalent Meningococcal Vaccine Among Persons Aged ≥10 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2025
title_full_unstemmed Use of the GSK MenACWY-CRM/MenB-4C Pentavalent Meningococcal Vaccine Among Persons Aged ≥10 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2025
title_short Use of the GSK MenACWY-CRM/MenB-4C Pentavalent Meningococcal Vaccine Among Persons Aged ≥10 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2025
title_sort use of the gsk menacwy-crm/menb-4c pentavalent meningococcal vaccine among persons aged ≥10 years: recommendations of the advisory committee on immunization practices - united states, 2025
topic — — — — — Demography and Population Studies
Psychology
Social Sciences
url https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=762789